Phaos Technology Holdings (Cayman) POAS
NYSE POAS
$0.16 +0.00 (+0.56%)
At close: Aug 20, 2026 · 2:25 PM UTC

Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Liabilities (2025)

Phaos Technology Holdings (Cayman)'s (POAS) quarterly Other Non-Current Liabilities came in at $1.9 million in Q2 2025.

Phaos Technology Holdings (Cayman) (POAS) Other Non-Current Liabilities (2025) Analysis & Trends

Phaos Technology Holdings (Cayman) (POAS) has 1 years of Other Non-Current Liabilities data on file, last reported at $1.9 million in Q2 2025.

  • Quarterly Other Non-Current Liabilities changed N/A year-over-year to $1.9 million in Q2 2025, while the trailing twelve-month figure through Apr 2025 was $1.9 million (changed N/A YoY) and the FY2025 annual result came in at $2.0 million, changed N/A from the prior year.
  • Other Non-Current Liabilities was little changed at $1.9 million in Q2 2025.
  • In the past five years, Other Non-Current Liabilities ranged from a high of $1.9 million in Q2 2025 to a low of $1.9 million in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 199.44 Bn 193.84 Bn 7.27 Bn
2 Stryker 127.32 Bn 123.85 Bn 4.50 Bn
3 Medtronic 118.87 Bn 109.65 Bn 6.41 Bn
4 Boston Scientific 73.47 Bn 72.93 Bn 3.85 Bn
5 Edwards Lifesciences 51.90 Bn 47.65 Bn 1.35 Bn
6 Dexcom 34.30 Bn 32.36 Bn 830.00 Mn
7 GE HealthCare Technologies 33.74 Bn 31.63 Bn 2.18 Bn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn
9 Steris 23.05 Bn 22.56 Bn 684.20 Mn
10 Phaos Technology Holdings (Cayman) 4.13 Mn 4.08 Mn -

Historic Data

Download Data
DateValue
Apr 30, 2025 1.95 Mn